News
On September 14, IPHARMA celebrated the fifth anniversary of the work in the market of clinical trials in the loft on ...
15.09.2017
Conjugate, a company of ChemRar Group and the resident of the BioMedical Cluster of the Skolkovo Foundation, has ...
11.09.2017
Moscow, June 24, 2017 — ELPIDA® (elsulfavirin), a new generation non-nucleoside reverse transcriptase inhibitor (NNRTI) ...
25.07.2017
At the St. Petersburg International Economic Forum held at the site of ASI Boiling Point, Andrey Ivashchenko, the ...
02.06.2017
On April 25, 2017 the Moscow Stadium Live concert hall hosted the final of GenerationS — the largest startup ...
04.05.2017
On April 21, 2017 Skolkovo held the Fifth Skolkovo Robotics International Conference 2017, organized by the Skolkovo ...
28.04.2017
ChemRar Group (ChemRar) has announced a successful completion of a safety and tolerability trial of a ...
25.04.2017
IPHARMA has maintained a leading position among contract research organizations in the volume of local drugs studies ...
21.04.2017